SUBSCRIBE
SUBSCRIBE

BioNTech

NEWS
Business
BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates Against Various Infectious Diseases
New research program between BioNTech and the University of Pennsylvania
November 15, 2018
 · 
4 min read
Business
BioNTech Inks $425 Million Collaboration Deal with Pfizer to Develop mRNA-based Flu Vaccines
BioNTech, headquartered in Mainz, Germany, and Pfizer, based in New York City, signed a multi-year research-and-development deal to develop mRNA-based flu vaccines.
August 16, 2018
 · 
2 min read
 · 
Mark Terry
Business
Roivant Taps Genentech Veteran as Operating Chair Ahead of Pipeline Day
Changes continue coming to Vivek Ramaswamy’s Roivant Sciences following a June shakeup that saw a 10 percent cut in employment and the restructuring of its business operations.
July 10, 2018
 · 
2 min read
 · 
Alex Keown
Business
BioNTech and Genevant Forge mRNA Therapeutics Development Agreement
BioNTech AG and Genevant Sciences entered into a strategic partnership to develop five therapeutics to treat rare diseases.
July 10, 2018
 · 
2 min read
 · 
Alex Keown
Business
Translate Bio and Sanofi Ink Potential $850 Million mRNA Vaccine Development Deal
Translate Bio, headquartered in Lexington, Massachusetts, and Paris-based Sanofi are teaming up to develop five vaccines.
June 11, 2018
 · 
2 min read
 · 
Mark Terry
Can 2018 Possibly Rival 2017’s Biotechs Record Ven
BioCapital
Can 2018 Possibly Rival 2017’s Biotechs Record Venture Capital Splurge?
A look at whether big money and big deals will be in store for 2018.
January 8, 2018
 · 
2 min read
 · 
Karl Thiel
Genentech Grows on Promise of 70+ Drug Approvals
Business
Genentech Gambles $310 Million+ on German Biotech BioNTech’s mRNA Cancer Vaccine Tech
September 21, 2016
 · 
2 min read
Load More
JOBS
IN THE PRESS
Press Releases
BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
 · 
13 min read
Press Releases
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund
January 12, 2026
 · 
6 min read
Press Releases
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
December 18, 2025
 · 
7 min read
Press Releases
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer
December 10, 2025
 · 
15 min read
Press Releases
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
December 8, 2025
 · 
14 min read
Press Releases
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
December 4, 2025
 · 
13 min read
Press Releases
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
November 27, 2025
 · 
15 min read
Press Releases
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates
November 24, 2025
 · 
18 min read
Press Releases
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
November 4, 2025
 · 
29 min read
Press Releases
BioNTech to Host Innovation Series R&D Day on November 11, 2025
October 29, 2025
 · 
1 min read
Load More